Xenon Pharmaceuticals
D

XENE

40.490
USD
-0.48
(-1.17%)
مغلق
آخر تحديث: · متأخرة 15 دقيقة
حجم التداول
19,000
الربح لكل سهم
-4
العائد الربحي
-
P/E
-9
حجم السوق
3,979,548,880
أصول ذات صلة

العنوان: Xenon Pharmaceuticals

القطاع: الرعاية الصحية
الصناعة: Biotechnology
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.

أسئلة شائعة حول سهم Xenon Pharmaceuticals